Ear-Zap device could curb teen Self-Harm

NCT ID NCT06433583

Recruiting now Prevention Sponsor: Centre Hospitalier Régional Metz-Thionville Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether teens aged 13-17 who self-harm will use a small ear device that stimulates the vagus nerve. The device is used at home for 10-20 minutes daily over 8 weeks. The main goal is to see if teens stick with the treatment, not yet whether it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous auricular vagal nerve stimulation (taVNS) device
What this could lead to: If this works, it could point toward a drug-free, at-home treatment to help teens reduce self-harm behaviors.
What could go wrong: This is a very small pilot study (22 teens) focused on whether teens will actually use the device, not on effectiveness. The device may not reduce self-harm, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHIATRIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychiatric disorder Self-Injurious Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSYCHIATRIC DISORDER

Contacts and locations

Locations

Centre Médico-Psychologique adolescents - CHR Metz-Thionville
RECRUITING

Thionville, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.